Updates are available Correction dated 2016-12-08
Click to view Correction: https://doi.org/10.1038/ncomms13775
-
Authors
Scheller, Erica L.
Doucette, Casey R.
Learman, Brian S.
Cawthorn, William P. https://orcid.org/0000-0001-7832-5057
Khandaker, Shaima
Schell, Benjamin
Wu, Brent
Ding, Shi-Ying
Bredella, Miriam A.
Fazeli, Pouneh K.
Khoury, Basma
Jepsen, Karl J.
Pilch, Paul F.
Klibanski, Anne
Rosen, Clifford J.
MacDougald, Ormond A.
- License Information
-
More Information
Article History
Received: 9 January 2015
Accepted: 12 June 2015
First Online: 6 August 2015
Change Date: 8 December 2016
Change Type: Update
Change Details: A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has not been fixed in the paper.
Competing interests
: O.A.M. holds stock in MRK and ESRX, and has received research funding from Eli Lilly and Company. W.P.C. received fellowship funding from Eli Lilly and Company. E.L.S. and O.A.M. have received research funding from Biomet Biologics. A.K. has received research funding from Rhythm Pharmaceuticals. The remaining authors declare no competing financial interests.
